Literature DB >> 21039542

Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods.

Leena Peltonen1, Jouni Hirvonen.   

Abstract

OBJECTIVES: Wet milling is a common technique to produce drug nanocrystals. Stability of the nanocrystals is a critical question, and different kinds of stabilizers, e.g. polymers, celluloses, surfactants and lipids, have been tested for various drugs. Still, the question about how to select the best stabilizer to a certain drug material and also to a selected process is open. KEY
FINDINGS: Many different factors, such as surface energy, hydrophobicity, solubility, viscosity and functional groups, affect the stability of the formed nanosuspensions. Affinity of the stabilizer to the particle surfaces seems to be the most important parameter. This affinity is partly related to the surface energy and hydrophobicity of the surfaces and stabilizers.
SUMMARY: In this review the most important factors affecting nanocrystal formulation and efficacy of stabilizers are presented. In order to widen understanding of the milling process, the most important variables related to milling techniques and particle fracturing processes during the milling are briefly presented.
© 2010 The Authors. Journal compilation © 2010 Royal Pharmaceutical Society of Great Britain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039542     DOI: 10.1111/j.2042-7158.2010.01022.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  48 in total

1.  Supersolubilization and amorphization of a model basic drug, haloperidol, by interaction with weak acids.

Authors:  Saumya Singh; Tapan Parikh; Harpreet K Sandhu; Navnit H Shah; A Waseem Malick; Dharmendra Singhal; Abu T M Serajuddin
Journal:  Pharm Res       Date:  2013-02-21       Impact factor: 4.200

2.  An Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.

Authors:  Meng Li; Lu Zhang; Rajesh N Davé; Ecevit Bilgili
Journal:  AAPS PharmSciTech       Date:  2015-07-17       Impact factor: 3.246

3.  Nano-extrusion: a one-step process for manufacturing of solid nanoparticle formulations directly from the liquid phase.

Authors:  Johannes Khinast; Ramona Baumgartner; Eva Roblegg
Journal:  AAPS PharmSciTech       Date:  2013-03-06       Impact factor: 3.246

4.  Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions.

Authors:  Peng Liu; Odile De Wulf; Johanna Laru; Teemu Heikkilä; Bert van Veen; Juha Kiesvaara; Jouni Hirvonen; Leena Peltonen; Timo Laaksonen
Journal:  AAPS PharmSciTech       Date:  2013-04-25       Impact factor: 3.246

Review 5.  An overview on in situ micronization technique - An emerging novel concept in advanced drug delivery.

Authors:  K R Vandana; Y Prasanna Raju; V Harini Chowdary; M Sushma; N Vijay Kumar
Journal:  Saudi Pharm J       Date:  2013-05-29       Impact factor: 4.330

6.  Interaction studies between indomethacin nanocrystals and PEO/PPO copolymer stabilizers.

Authors:  Peng Liu; Tapani Viitala; Alma Kartal-Hodzic; Huamin Liang; Timo Laaksonen; Jouni Hirvonen; Leena Peltonen
Journal:  Pharm Res       Date:  2014-08-22       Impact factor: 4.200

Review 7.  Mechanistic Modeling of Wet Stirred Media Milling for Production of Drug Nanosuspensions.

Authors:  E Bilgili; G Guner
Journal:  AAPS PharmSciTech       Date:  2020-11-22       Impact factor: 3.246

8.  Smart Nanoparticles for Drug Delivery: Boundaries and Opportunities.

Authors:  Byung Kook Lee; Yeon Hee Yun; Kinam Park
Journal:  Chem Eng Sci       Date:  2015-03-24       Impact factor: 4.311

Review 9.  Process optimization and particle engineering of micronized drug powders via milling.

Authors:  A Brunaugh; H D C Smyth
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

Review 10.  Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.

Authors:  Lei Gao; Guiyang Liu; Jianli Ma; Xiaoqing Wang; Liang Zhou; Xiang Li; Fang Wang
Journal:  Pharm Res       Date:  2012-10-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.